{
    "clinical_study": {
        "@rank": "121091", 
        "arm_group": [
            {
                "arm_group_label": "electronic cigarette", 
                "arm_group_type": "Experimental", 
                "description": "electronic cigarette 24mg cartridges; 1-2 cartridges daily"
            }, 
            {
                "arm_group_label": "nicotine inhaler", 
                "arm_group_type": "Active Comparator", 
                "description": "nicotine inhaler 10mg cartridge; max 16 cartridges daily"
            }
        ], 
        "brief_summary": {
            "textblock": "Electronic cigarettes have shown promise but have yet to proven effective for smoking\n      cessation. This trial will evaluate the effectiveness of electronic cigarettes in smokers\n      who are trying to quit smoking compared with a standard therapy, the nicotine inhaler. The\n      investigators hypothesize that electronic cigarettes will be comparable to the nicotine\n      inhaler in terms of smoking cessation."
        }, 
        "brief_title": "Electronic Cigarettes or Nicotine Inhaler for Smoking Cessation", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Tobacco Use Disorder", 
        "condition_browse": {
            "mesh_term": [
                "Smoking", 
                "Tobacco Use Disorder"
            ]
        }, 
        "detailed_description": {
            "textblock": "Cigarette smoking remains the leading cause of preventable death and disease worldwide.\n\n      The purpose of this trial is to evaluate the effectiveness of electronic cigarettes for\n      smoking cessation compared to a similar nicotine replacement therapy, the nicotine inhaler."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18-60 year old\n\n          -  Meet DSM-IV criteria for nicotine dependence\n\n          -  Seeking treatment for smoking cessation\n\n          -  Smoking at least 15 cigarettes per day\n\n          -  Capable of giving informed consent and complying with study procedures\n\n        Exclusion Criteria:\n\n          -  Lifetime history of DSM-IV diagnosis of schizophrenia, schizoaffective disorder, and\n             bipolar disorder or current diagnosis of major depressive disorder\n\n          -  Current DSM-IV criteria for any other psychiatric disorder that may, according to the\n             investigator's judgment, require either pharmacological or non- pharmacological\n             intervention over the course of the study\n\n          -  Currently receiving any treatment for nicotine dependence, including nicotine\n             replacement therapy\n\n          -  Pregnancy, lactation, or failure to use adequate contraception methods in women who\n             are currently having sex with men\n\n          -  Unstable medical condition, such as uncontrolled hypertension, angina, and\n             oropharyngeal conditions which may make participation hazardous\n\n          -  Current DSM-IV diagnosis of substance dependence, other than nicotine\n\n          -  Use of cannabis or alcohol on more than 20 days in the past 30 days\n\n          -  Risk for suicide"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02004171", 
            "org_study_id": "P50DA009236-20", 
            "secondary_id": "P50DA009236-20"
        }, 
        "intervention": [
            {
                "arm_group_label": "electronic cigarette", 
                "description": "V2 Cigs with 24 mg nicotine cartridges", 
                "intervention_name": "electronic cigarette", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "nicotine inhaler", 
                "description": "nicotine inhaler with 10 mg nicotine cartridges", 
                "intervention_name": "nicotine inhaler", 
                "intervention_type": "Drug", 
                "other_name": "Nicotrol inhaler"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Nicotine", 
                "Nicotine polacrilex"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "electronic cigarette", 
            "nicotine inhaler", 
            "smoking cessation"
        ], 
        "lastchanged_date": "December 2, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10032"
                }, 
                "name": "Substance Treatment and Research Services (STARS)"
            }, 
            "investigator": {
                "last_name": "Barney Vaughan, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Electronic Nicotine Delivery Devices (ENDDs) or Nicotine Inhaler for Smoking Cessation", 
        "other_outcome": {
            "description": "We will measure if body mass increases as a consequence of smoking cessation.", 
            "measure": "Body mass index", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "overall_contact": {
            "email": "vaughan@nyspi.columbia.edu", 
            "last_name": "Barney Vaughan, MD", 
            "phone": "9176901910"
        }, 
        "overall_official": {
            "affiliation": "New York State Psychiatric Institute/Columbia University", 
            "last_name": "Barney Vaughan, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Cigarettes smoked over 24 hours", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02004171"
        }, 
        "responsible_party": {
            "investigator_affiliation": "New York State Psychiatric Institute", 
            "investigator_full_name": "Barney Vaughan", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "We will measure the incidence and severity of nicotine withdrawal symptoms, including irritability, anxiety, depressed mood and increased appetite.", 
                "measure": "Symptoms of nicotine withdrawal", 
                "safety_issue": "No", 
                "time_frame": "4 weeks"
            }, 
            {
                "description": "we will measure perceived benefits from smoking cessation including improved breathing, improved sense of taste and smell, and improved physical fitness.", 
                "measure": "Benefits from smoking cessation", 
                "safety_issue": "No", 
                "time_frame": "4 weeks"
            }, 
            {
                "description": "we will assess for any possible side effect from the electronic cigarette or the nicotine inhaler, including irritation of the mouth and throat and cough.", 
                "measure": "Adverse reaction to nicotine inhaler or electronic cigarette", 
                "safety_issue": "Yes", 
                "time_frame": "4 weeks"
            }
        ], 
        "source": "New York State Psychiatric Institute", 
        "sponsors": {
            "collaborator": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "New York State Psychiatric Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}